Medicine and Dentistry
Cohort Analysis
100%
Hazard Ratio
39%
Disease
38%
Breast Cancer
32%
Systematic Review
25%
Multiple Chronic Conditions
24%
Single Nucleotide Polymorphism
22%
Meta-Analysis
21%
Diabetes
21%
Pharmacokinetics
20%
Messenger RNA
20%
Chemotherapy
19%
Medicine
18%
Randomized Controlled Trial
18%
Premenopause
16%
Opiate
16%
Physician
16%
Drug Interaction
16%
Malignant Neoplasm
14%
Drug Therapy
13%
Injury
13%
Docetaxel
12%
Proportional Hazards Model
11%
Meta-Regression
11%
Patient Referral
10%
Cohort Effect
10%
Comorbidity
10%
Patient Registry
9%
Birth Outcomes
9%
Conception
9%
Antibiotics
9%
Cardiovascular System
9%
COVID-19
9%
Patient Care
8%
Asthma
8%
Placebo
8%
Hormonal Contraception
8%
Dihydropyrimidine Dehydrogenase
8%
Childhood Cancer
8%
Drug Effect
8%
Population Health
8%
Diagnosis Code
8%
Antidiabetic Agent
8%
Fetus Death
8%
Paternal Exposure
8%
Case-Control Study
8%
Clonidine
8%
Antiinflammatory Agent
8%
Evidence-Based Medicine
8%
Arterial Blood Gas Analysis
8%
Chronic Kidney Disease
8%
Fragility Fracture
8%
Morphine
8%
Phthalic Acid
8%
General Medicine
8%
Sensorineural Hearing Loss
8%
Gabapentin
8%
Symptomatic Treatment
8%
Medical Specialty
8%
Obstetrics
8%
Clinical Oncology
8%
Cancer Incidence
8%
Pharmacodynamics
8%
Drusen
8%
Omicron Coronavirus Variant
8%
Diet and Cancer
8%
Chronic Disease
8%
Hospital Mortality
8%
Urinary Tract Infection
8%
Nicotine Withdrawal
8%
Procedure Code
8%
Myocardial Infarction
8%
Apoplexy
8%
Patient with Type 1 Diabetes
8%
Diabetic Retinopathy
8%
Post-Hoc Analysis
8%
COVID-19 Vaccine
8%
Artery Puncture
8%
Sodium Valproate
8%
Immunity
8%
Silo-Filler's Disease
8%
Osteogenesis Imperfecta
8%
Methotrexate
8%
Rheumatoid Arthritis
8%
Osteopathic Medicine
8%
Inflammatory Arthritis
8%
Safety Assessment
8%
CYP1A2
8%
In Vitro
8%
Congenital Malformation
7%
Homozygote
6%
Pregabalin
6%
Subgroup Analysis
6%
Aortic Aneurysm
6%
Tumor Spheroid
6%
Spontaneous Abortion
6%
Drug Megadose
6%
Maturity Onset Diabetes of the Young
6%
Cumulative Incidence
5%
Small for Gestational Age
5%
Pharmacology, Toxicology and Pharmaceutical Science
Cohort Study
80%
Messenger RNA
42%
Asthma
24%
Cerebrovascular Accident
24%
Breast Cancer
24%
Prevalence
21%
Congenital Malformation
21%
Comorbidity
20%
Chemotherapy
19%
Opiate
18%
Flucloxacillin
17%
CYP3A4
17%
Chronic Kidney Failure
17%
Case-Control Study
16%
Drug Utilization
16%
Heart Infarction
16%
Randomized Controlled Trial
16%
Osteogenesis Imperfecta
16%
Pregabalin
14%
Pharmacokinetics
13%
Malignant Neoplasm
13%
CYP1A2
12%
Adverse Event
12%
COVID-19 Vaccine
12%
Antidiabetic Agent
12%
Docetaxel
12%
P-Glycoprotein
11%
Taxane
11%
Disease
10%
Cytochrome P450
10%
Recurrent Disease
10%
Morphine
9%
Observational Study
9%
Dicloxacillin
9%
Rifampicin
9%
Drug Interaction
9%
Epidemiology
9%
Clinical Pharmacokinetics
8%
CYP2B6
8%
Tablet
8%
Gabapentinoid
8%
Event Free Survival
8%
Clonidine
8%
Digitalis Glycoside
8%
Normal Human
8%
Clinical Trial
8%
Loop Diuretic Agent
8%
Childhood Cancer
8%
Serotonin Syndrome
8%
Triacylglycerol
8%
Life Expectancy
8%
Edema
8%
Antiemetic Agent
8%
Statin (Protein)
8%
Quetiapine
8%
Antidepressant
8%
Pharmacodynamics
8%
Perception Deafness
8%
Pharmacovigilance
8%
Tricyclic Antidepressant
8%
Glucocorticoid
8%
Drug Screening
8%
Gabapentin
8%
Phthalic Acid
8%
Glycosylated Hemoglobin
8%
Fragility Fracture
8%
Endocrine Therapy
8%
Cancer Incidence
8%
Balsalazide
8%
Serotonin
8%
Triptan Derivative
8%
Hospital Mortality
8%
Injury
8%
Appendicitis
8%
Brain Hemorrhage
8%
All Cause Mortality
8%
Insulin Dependent Diabetes Mellitus
8%
Diabetic Retinopathy
8%
Ethanol
8%
Cross-Sectional Study
8%
Placebo
8%
Chemotherapy-Induced Peripheral Neuropathy
8%
Pregnancy Complication
8%
Sodium Valproate
8%
Direct Oral Anticoagulant
8%
Lung Disease
8%
Rheumatoid Arthritis
8%
Methotrexate
8%
Inflammatory Arthritis
8%
Safety Assessment
8%
Drug-Drug Interaction
8%
Clinical Pharmacology
6%
Cannabis
6%
Non Insulin Dependent Diabetes Mellitus
6%
Effusion
5%
Prednisolone
5%
Ischemic Heart Disease
5%
CYP2C9
5%
Antibiotics
5%
Nausea
5%
Biochemistry, Genetics and Molecular Biology
Cohort Study
50%
Digital Positive Youth Development
24%
Genotyping
22%
Dihydropyrimidine Dehydrogenase
19%
Single-Nucleotide Polymorphism
16%
Genetic Divergence
16%
Drug Interaction
16%
Blood Level
13%
Premenopause
12%
Pharmacokinetics
12%
Smoking Cessation
9%
CYP1A2
8%
Hemoglobin Blood Level
8%
Cholesterol Level
8%
Randomized Controlled Trial
8%
Drug Screening
8%
Triacylglycerol Level
8%
Glycated Hemoglobin
8%
Statin
8%
Case-Control Study
8%
Low Drug Dose
8%
Clinical Trial
8%
Conception
8%
Morphine-3-Glucuronide
8%
Lipid
8%
Morphine-6-Glucuronide
8%
Hospital Mortality
8%
Induced Pluripotent Stem Cell
8%
Sensory Neuron
8%
Gabapentin
8%
Comorbidity
8%
Bone Development
8%
Tumor Spheroid
8%
Messenger RNA
7%
Allele
6%
Pregabalin
6%
Small Molecule
6%
SLCO1B1
6%
Prevalence
5%
Clinical Pharmacology
5%
Smoking
5%